HMG—CoA还原酶抑制剂的全身免疫反应4全报告和文献复习
出处
《世界医学杂志》
2000年第10期64-67,共4页
International Journal of Medicine
参考文献25
-
1Abroad S, Lovastatininduced lupus erythematosus. Arch Intern. Med 1991;151:1667-68.
-
2Ballare M, Campanini M, Airoldi G, Zaccala G, Bertoncelli MC, Comaglia G,Porzio M,Monteverde A.Hepatotoxicity of HMG CO-A reductase inhibitors.Mincra Gastroenterol Dietol 1992; 38: 41-44.
-
3Bannwarth B, Miremont G, Papapietro P-M. Lupuslike syndrome associated with simvastatin.Arch Intern Med 1992; 152: 1093.
-
4Bradford RH, Shear CL. Chremos AN, Dujovne C, Downton M, Franklin FA,Gould AL, Hesney M,Higgins J, Hurley DP, et al.Expanded Clinical Evaluation of Lovastatin(EXCEL) study results. Arch Intern Med 1991; 151: 4349.
-
5Bui MN, Sack MN, Moutsatsos G, Lu DY, Katz P McCown R, Breall JA.Rackley CE. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis.Am Heert J 1996; 131: 663-67.
-
6Careless DJ, Cohen MG. Rheumatic manifestations of hyperlipidemia and antihyperlipidemia drug therapy. Semin Arthritis Rheum 1993; 23: 90-98.
-
7Coblyn JS, Weinblatt ME. Rheumatic diseases and the heart. In:Braunwald E. Heart disease.A textbook of cardiovascular medicine 5th ed. Philadelphia:WB Saunders, 1997. p. 1778.
-
8Fosso C, Miller M, Solomon W, Baker J. Advecse effccts of HMG Co-A reductase inhibitors associated with elevated serum IgE and eosinophilia.J Allergy Clin Immunol 1995; 95: 1053-55.
-
9Fritzler MJ, Rubin RL. Drug-induced lupus erythematosus.In:Wallace DJ, Rubin RL. Drug-induced lupus erythematosus.3rd. ed. Philadelphia:Lea & Febigcr,1987. p. 442.
-
10Gillis MC, ed. Compendium of pbarmaoeuticals and specialties. 32nd ed. Ottawa,Ontario.Canada: Canadian Pbarmaceutical Aasociation,1997. p. 1803.
